|
Market Closed -
Nasdaq Stockholm
17:00:00 03/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 420.30 SEK | +0.07% |
|
+0.89% | +27.87% |
| 11-03 | Mölnlycke appoints Anders Andersson as new CEO | FW |
| 11-02 | Atlas Antibodies changes CEO - Morten Henneveld takes over on an interim basis | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| INVE A | Delayed | |
CBOE
| INVEAs | Real-time | |
|
Tradegate
| IVS | Real-time | |
|
London S.E.
| 0NC5 | Delayed | |
|
OTC Markets
| IVSXF | Delayed | |
|
Boerse Muenchen
| IVS | Real-time | |
|
Deutsche Boerse AG
| IVS | Delayed | |
|
Xetra
| IVS | Delayed | |
|
CBOE
| 0NC5 | Real-time | |
|
Börse Stuttgart
| IVS | Delayed | |
Nasdaq Stockholm
| INVE B | Delayed | |
|
CBOE
| INVEBs | Real-time | |
|
Tradegate
| IVSD | Real-time | |
|
OTC Markets
| IVSBF | Delayed | |
|
London S.E.
| 0NC6 | Delayed | |
|
Boerse Muenchen
| IVSD | Real-time | |
|
Börse Stuttgart
| IVSD | Delayed | |
|
Mexican S.E.
| INVEB N | End-of-day quote | |
|
Xetra
| IVSD | Delayed | |
|
Berne S.E.
| IVSD | End-of-day quote | |
|
Deutsche Boerse AG
| IVSD | Delayed | |
|
CBOE
| 0NC6 | Real-time | |
|
Borsa Italiana
| 1INVEB | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 431.28 | 446.02 | 462.42 |
| Spread/Res. | -2.55% | -5.77% | -9.11% |
| Spread/Supp. | +3.88% | +6.84% | +12.38% |
| Support | 404.6 | 393.4 | 374 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- INVE A Stock
- Charts Investor AB
Select your edition
All financial news and data tailored to specific country editions
